NCT06947148Completed
The Impact of Comprehensive Post Hospital Management Based on DHI on Cardiac Function in Patients With HF
The Impact of Comprehensive Post Hospital Management Based on Digital Health Intervention on Cardiac Function in Patients With Heart Failure: a Prospective, Multicenter, Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 4 Mar 2026
Brief summary (registry, in English)
Due to the complex nature of HF patients' conditions, long-term treatment and management are required, especially post hospital management, which is of great significance for improving patients' cardiac function and quality of life. With the increasing popularity of smartphones and the continuous development of medical technology, digital health intervention (DHI) has emerged as a new medical model in the treatment of diseases. This study will establish a comprehensive post hospital management model of HF based on DHI, including cognitive behavioral therapy, digital self-monitoring and remote dielectric sensing (ReDS™) technology, etc., comprehensively strengthen the post hospital intervention and management of HF. Objective to explore the effect of comprehensive post hospital management based on DHI on cardiac function of patients with HF 6 months after discharge.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 104 (actual)
- First submitted
- 21 Apr 2025
- Start date
- 1 Apr 2025
- Primary completion date
- 18 Jul 2025
- Lead sponsor
- Harbin Medical University
- Diseases
- Heart failure
- NCT number
- NCT06947148
What you commit to
- Study type: Interventional
- Participants enrolled: 104
- From 1 Apr 2025 to the primary completion date, 18 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently participating in clinical trials of other devices or drugs
Other illness
- History of pulmonary embolism
- chronic renal failure（Scr \> 443umol/L）
- History of heart transplantation or pacemaker implantation
- Severe pulmonary hypertension
- Suffering from end-stage chronic obstructive pulmonary disease, requiring home oxygen therapy
- Researchers believe that participants are not suitable to participate in this trial (such as pregnancy, severe visual or hearing impairment, etc.)
- Individuals who are unable to understand and/or comply with this research procedure (such as those who are addicted to alcohol, substance abuse, or have mental illnesses)
Age
- Age\<21 years old
Other
- Patients with height\<155 cm or\>190 cm, BMI\<22 kg/m2 or\>36 kg/m2, chest circumference\<80 cm or\>115 cm, and flail chest or rib fractures
- Massive pleural effusion
- The subject is unable to complete the 6-minute walking test
- Expected lifespan\<6 months
- Researchers involved in the design and execution of this study
Who the study is looking for
- Patients hospitalized for HF, NYHA classification II-IV upon admission
- The patient's residence is within the urban area of each center, and ReDS™ technology can be performed at home or at the outpatient clinic
- No difficulty using smartphones, with basic Chinese reading and writing skills
- Accept the terms and conditions of the study and obtain informed consent from the subjects/their families
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Second Affiliated Hospital of Harbin Medical University Coordinator of this site? Confirm its status | Harbin | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.